Mirum Pharmaceuticals, Inc. announced that on July 10, 2023, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 44,850 shares of common stock and 22,430 restricted stock units to ten new employees under Mirum’s 2020 Inducement Plan.
